# A Single-Arm Clinical Study of Autologous Tumor-Infiltrating Lymphocyte Injection (GT307) in the Treatment of Metastatic and Recurrent Advanced Solid Tumors

> **NCT07534813** · NA · NOT_YET_RECRUITING · sponsor: **Grit Biotechnology** · enrollment: 16 (estimated)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **BIOLOGICAL:** GT307 injection

## Key facts

- **NCT ID:** NCT07534813
- **Lead sponsor:** Grit Biotechnology
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-30
- **Primary completion:** 2028-05-31
- **Final completion:** 2028-05-31
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2026-04-16

## Collaborators

- Fudan University

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07534813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07534813, "A Single-Arm Clinical Study of Autologous Tumor-Infiltrating Lymphocyte Injection (GT307) in the Treatment of Metastatic and Recurrent Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07534813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*